EDX Medical Group PLC (EDX) · 2026-10-30
Leading industry figure appointed chair
EDX Medical Group has appointed Professor Michael John Owen as non-executive Chairman with immediate effect, succeeding Jason Holt in a planned board transition.
EDX Medical Group plc (EDX) · 2026-09-17
Employee health contract with Arnold Clark Group
EDX Medical has signed an initial three-year employee health screening agreement with Arnold Clark Group, expected to generate annual revenues of between £1.4 and £1.6million. The forecast assumes high participation from eligible employees.
EDX Medical Group plc (EDX) · 2026-08-27
Scottish Prostate Cancer Initiative update
EDX Medical has begun a new phase testing 12,500 men in the Scottish Prostate Cancer Initiative, with 31 sessions planned from this week until November.
EDX Medical Group plc (EDX) · 2026-08-03
Rapid pneumonia test deployed for NHS patients
EDX Medical has deployed its rapid pneumonia test at Addenbrooke's Hospital under a four-year agreement with Cambridge University Hospitals NHS Foundation Trust, while wider UK and European supply requires regulatory approval.
EDX Medical Group plc (EDX) · 2026-07-21
Full launch of bowel cancer testing service (BC95)
EDX Medical has made its BC95 bowel cancer biomarker testing service fully available in the UK. The service uses three component tests and includes EarlyTect®, which showed average sensitivity of 95% in a study of 1,124 asymptomatic patients.
EDX Medical Group plc (EDX) · 2026-07-15
Launch of employee health screening service
EDX Medical has reached agreement in principle with three significant UK employers covering 14,000 employees for employee health screening, subject to final documentation. Testing is expected to start in Q4 this calendar year.
EDX Medical Group plc (EDX) · 2026-07-08
EDX Medical service agreement with Astron Health
EDX Medical has been appointed to provide molecular profiling products and services to Astron Health Ltd. The UK agreement covers Caris MI Profile™ and Caris Assure® tests.